Hiperfractionated (HFRT) versus Standard Radiotherapy (SRT) in Locally Advanced (LA) NSCLC: a metaanalysis of randomized phase III trials.

MLA

Nasroulah, Federico, et al. “Hiperfractionated (HFRT) versus Standard Radiotherapy (SRT) in Locally Advanced (LA) NSCLC: A Metaanalysis of Randomized Phase III Trials.” Journal of Thoracic Oncology, vol. 2, Aug. 2007, pp. S477–78. EBSCOhost, https://doi.org/10.1097/01.JTO.0000283433.97261.8e.

APA

Nasroulah, F., O, connor, J. M., Van Kooten, M., Tajer, C., & Chacon, R. D. (2007). Hiperfractionated (HFRT) versus Standard Radiotherapy (SRT) in Locally Advanced (LA) NSCLC: a metaanalysis of randomized phase III trials. Journal of Thoracic Oncology, 2, S477–S478. https://doi.org/10.1097/01.JTO.0000283433.97261.8e

Chicago

Nasroulah, Federico, connor, Juan M. O, Maximiliano Van Kooten, Carlos Tajer, and Reinaldo D. Chacon. 2007. “Hiperfractionated (HFRT) versus Standard Radiotherapy (SRT) in Locally Advanced (LA) NSCLC: A Metaanalysis of Randomized Phase III Trials.” Journal of Thoracic Oncology 2 (August): S477–78. doi:10.1097/01.JTO.0000283433.97261.8e.